The importance of metrological traceability on the validity of creatinine measurement as an index of renal function: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
-
Mauro Panteghini
Abstract
The glomerular filtration rate (GFR) is currently considered the best overall index of kidney function. The possibility that laboratories might routinely report an estimated GFR has become practically feasible with the development of a formula, the “four-variable” Modification of Diet in Renal Disease study (MDRD) equation that uses age, sex, race, and serum creatinine parameters. However, a limitation of this equation for general implementation in healthcare is related to the use of differently calibrated creatinine measurement procedures among laboratories. The only way to achieve universal implementation of the GFR prediction equation, with the associated clinical benefits for patients, is, therefore, to promote worldwide standardization of methods to determine creatinine, together with the introduction of a revised GFR-estimating equation appropriate for use with standardized creatinine methods.
Clin Chem Lab Med 2006;44:1287–92.
References
1. El Nahas AM, Bello AK. Chronic kidney disease: the global challenge. Lancet 2005; 365:331–40.10.1016/S0140-6736(05)17789-7Search in Google Scholar
2. Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, Greene T, et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 2006; 52:5–18.10.1373/clinchem.2005.0525144Search in Google Scholar
3. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41:1–12.10.1053/ajkd.2003.50007Search in Google Scholar
4. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002;39:S1–246.Search in Google Scholar
5. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresch J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67:2089–100.10.1111/j.1523-1755.2005.00365.xSearch in Google Scholar
6. Flynn FV. Assessment of renal function: selected developments. Clin Biochem 1990; 23:49–54.10.1016/0009-9120(90)90435-WSearch in Google Scholar
7. Cohen EP, Lemann J. The role of the laboratory in evaluation of kidney function. Clin Chem 1991; 37:785–96.10.1093/clinchem/37.6.785Search in Google Scholar
8. Swan SK. The search continues – an ideal marker of GFR. Clin Chem 1997; 43:913–4.10.1093/clinchem/43.6.913Search in Google Scholar
9. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992; 38:1933–53.10.1093/clinchem/38.10.1933Search in Google Scholar
10. Price CP, Finney H. Developments in the assessment of glomerular filtration rate. Clin Chim Acta 2000; 297:55–66.10.1016/S0009-8981(00)00233-3Search in Google Scholar
11. Larsson A. Cystatin C: an emerging glomerular filtration rate marker. Scand J Clin Lab Invest 2005; 65:89–91.10.1080/00365510510013866Search in Google Scholar PubMed
12. Stevens LA, Levey AS. Chronic kidney disease in the elderly – how to assess risk? N Engl J Med 2005; 352:2122–4.10.1056/NEJMe058035Search in Google Scholar PubMed
13. Lamb EJ, Tomson CR, Roderick PJ. Estimating kidney function in adults using formulae. Ann Clin Biochem 2005; 42:321–45.10.1258/0004563054889936Search in Google Scholar PubMed
14. Levey AS, Greene T, Kusek JW, Beck GJ, Group MS. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11:A0828.Search in Google Scholar
15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130:461–70.10.7326/0003-4819-130-6-199903160-00002Search in Google Scholar PubMed
16. Lewis J, Agodoa L, Cheek D, Greene T, Middleton J, O'Connor D, et al. African-American Study of Hypertension and Kidney Disease. Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. Am J Kidney Dis 2001; 38:744–53.10.1053/ajkd.2001.27691Search in Google Scholar PubMed
17. Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002; 39:920–9.10.1053/ajkd.2002.32765Search in Google Scholar PubMed
18. Wuyts B, Bernard D, Van Den Noortgate N, Van De Valle J, Van Vlem B, De Smet R, et al. Reevaluation of formulas for predicting creatinine clearance in adults and children, using compensated creatinine methods. Clin Chem 2003; 49:1011–4.10.1373/49.6.1011Search in Google Scholar PubMed
19. Lamb EJ, Wood J, Stowe HJ, O'Riordan SE, Webb MC, Dalton RN. Susceptibility of glomerular filtration rate estimations to variations in creatinine methodology: a study in older patients. Ann Clin Biochem 2005; 42:11–8.10.1258/0004563053026899Search in Google Scholar PubMed
20. Hallan S, Asberg A, Lindberg M, Johnsen H. Validation of the Modification of Diet in Renal Disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. Am J Kidney Dis 2004; 44:84–93.10.1053/j.ajkd.2004.03.027Search in Google Scholar PubMed
21. McKillop DJ, Cairns B, Duly E, Van Drimmelen M, Ryan M. The effect of serum creatinine method choice on estimated glomerular filtration rate determined by the abbreviated MDRD formula. Ann Clin Biochem 2006; 43:220–2.10.1258/000456306776865098Search in Google Scholar PubMed
22. Van Biesen W, Vanholder R, Veys N, Verbeke F, Delanghe J, De Bacquer D, et al. The importance of standardization of creatinine in the implementation of guidelines and recommendations for CKD: implications for CKD management programmes. Nephrol Dial Transplant 2006; 21:77–83.10.1093/ndt/gfi185Search in Google Scholar PubMed
23. Seccombe DW, Tholen D, Jacobson BE. Standardization of creatinine: a pre-requisite for implementing the MDRD formula for the estimation of glomerular filtration rate (eGFR). Clin Chem 2005; 51(Suppl):A44.Search in Google Scholar
24. Miller WG, Myers GL, Ashwood ER, Killeen AA, Wang E, Thienpont LM, et al. Creatinine measurement: state of the art in accuracy and inter-laboratory harmonization. Arch Pathol Lab Med 2005; 129:297–304.10.5858/2005-129-297-CMSOTASearch in Google Scholar
25. Panteghini M, Forest JC. Standardization in laboratory medicine: new challenges. Clin Chim Acta 2005; 355:1–12.10.1016/j.cccn.2004.12.003Search in Google Scholar
26. Siekmann L. Measurement of creatinine in human serum by isotope dilution mass spectrometry. J Clin Chem Clin Biochem 1985; 23:137–44.Search in Google Scholar
27. Welch MJ, Cohen A, Hertz HS, Ng KJ, Schaffer R, Van Der Lijn P, et al. Determination of serum creatinine by isotope dilution mass spectrometry as a candidate definitive method. Anal Chem 1986; 58:1681–5.10.1021/ac00121a018Search in Google Scholar
28. Stöckl D, Reinauer H. Candidate reference methods for the determination of target values for cholesterol, creatinine, uric acid and glucose in external quality assessment and internal accuracy control. I. Method setup. Clin Chem 1993; 39:993–1000.10.1093/clinchem/39.6.993Search in Google Scholar
29. Stokes P, O'Connor G. Development of a liquid chromatography-mass spectrometry method for the high-accuracy determination of creatinine in serum. J Chromatogr B 2003; 794:125–36.10.1016/S1570-0232(03)00424-0Search in Google Scholar
30. Séronie-Vivien S, Galteau MM, Carlier MC, Hadj-Aissa A, Hanser AM, Hym B, et al. Impact of standardized calibration on the inter-assay variation of 14 automated assays for the measurement of creatinine in human serum. Clin Chem Lab Med 2005; 43:1227–33.10.1515/CCLM.2005.213Search in Google Scholar PubMed
31. Miller WG, Myers GL, Rej R. Why commutability matters. Clin Chem 2006; 52:553–4.10.1373/clinchem.2005.063511Search in Google Scholar PubMed
32. Clinical and Laboratory Standards Institute. Metrological traceability and its implementation; A report. CLSI document X5-R. Wayne, PA: CLSI, 2006.Search in Google Scholar
33. Clinical and Laboratory Standards Institute. Preparation and validation of commutable frozen human serum pools as secondary reference materials for cholesterol measurement procedures; Approved guideline. CLSI document C37-A. Wayne, PA: CLSI, 1999.Search in Google Scholar
34. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek J, et al. Expressing the MDRD study equation for estimating GFR with IDMS traceable (gold standard) serum creatinine values. J Am Soc Nephrol 2005; 16:69a.Search in Google Scholar
35. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Off J Eur Communities L 1998;L331:1–37.Search in Google Scholar
36. Örnemark U, Van Nevel L, Smeyers P, Harper C, Taylor PD. The international Measurement Evaluation Program IMEP-17. Trace and minor constituents in human serum. EUR 20694 EN. Report to participants. Part 2: Methodology and quantity specifications. www.imep.ws. Accessed June 12, 2006.Search in Google Scholar
37. Junge W, Wilke B, Halabi A, Klein G. Determination of reference intervals for serum creatinine, creatinine excretion and creatinine clearance with an enzymatic and a modified Jaffé method. Clin Chim Acta 2004; 344:137–48.10.1016/j.cccn.2004.02.007Search in Google Scholar PubMed
38. Khatami Z, Dey D, Handley G, Klein G, Nagel R, Becher D. In the name of traceability. Author's reply. Ann Clin Biochem 2005; 42:162–3.Search in Google Scholar
©2006 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Multiplexed testing in the autoimmunity laboratory
- Uncertainty calculation for calibrators and controls of laboratory diagnostic assays
- Westgard multirule for calculated laboratory tests
- Frequency of a single nucleotide (A2317G) and 56-bp variable number of tandem repeat polymorphisms within the deoxyribonuclease I gene in five ethnic populations
- The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function
- Apolipoprotein B gene 3′VNTR polymorphism: association with plasma lipids and coronary heart disease in Han Chinese
- Paraoxonase-1 (PON1) activity, but not PON1Q192R phenotype, is a predictor of coronary artery disease in a middle-aged Serbian population
- A modified method of prothrombin time/International Normalised Ratio determination in capillary blood and monitoring oral anticoagulant therapy
- Inhibition of the ubiquitin-proteasome system: a new avenue for atherosclerosis
- Lipid peroxidation and antioxidative status in β-thalassemia major patients with or without hepatitis C virus infection
- Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males
- Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum
- Effect of nitrogen mustard, a vesicant agent, on lymphocyte energy metabolism
- Partitioning reference values of several Gaussian subpopulations with unequal prevalence – a procedure with computer program support
- Biovariability of plasma adiponectin
- Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood
- Innotrac Aio!: a point-of-care or a routine analyzer? Analytical performance and plasma/whole blood comparison
- Serologic associations of anti-cytoplasmic antibodies identified during anti-nuclear antibody testing
- The importance of metrological traceability on the validity of creatinine measurement as an index of renal function: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
- Effect of seropositive rheumatoid factor on cardiac troponin I measurement using the Access® Immunoassay Analyzer
Articles in the same Issue
- Multiplexed testing in the autoimmunity laboratory
- Uncertainty calculation for calibrators and controls of laboratory diagnostic assays
- Westgard multirule for calculated laboratory tests
- Frequency of a single nucleotide (A2317G) and 56-bp variable number of tandem repeat polymorphisms within the deoxyribonuclease I gene in five ethnic populations
- The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function
- Apolipoprotein B gene 3′VNTR polymorphism: association with plasma lipids and coronary heart disease in Han Chinese
- Paraoxonase-1 (PON1) activity, but not PON1Q192R phenotype, is a predictor of coronary artery disease in a middle-aged Serbian population
- A modified method of prothrombin time/International Normalised Ratio determination in capillary blood and monitoring oral anticoagulant therapy
- Inhibition of the ubiquitin-proteasome system: a new avenue for atherosclerosis
- Lipid peroxidation and antioxidative status in β-thalassemia major patients with or without hepatitis C virus infection
- Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males
- Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum
- Effect of nitrogen mustard, a vesicant agent, on lymphocyte energy metabolism
- Partitioning reference values of several Gaussian subpopulations with unequal prevalence – a procedure with computer program support
- Biovariability of plasma adiponectin
- Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood
- Innotrac Aio!: a point-of-care or a routine analyzer? Analytical performance and plasma/whole blood comparison
- Serologic associations of anti-cytoplasmic antibodies identified during anti-nuclear antibody testing
- The importance of metrological traceability on the validity of creatinine measurement as an index of renal function: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
- Effect of seropositive rheumatoid factor on cardiac troponin I measurement using the Access® Immunoassay Analyzer